These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 3006089)

  • 1. Opioid-hallucinogen interactions.
    Domino EF
    Pharmacol Biochem Behav; 1986 Feb; 24(2):401-5. PubMed ID: 3006089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selected opioid agonists and antagonists on DMT- and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat.
    Ruffing DM; Domino EF
    Psychopharmacology (Berl); 1981; 75(3):226-30. PubMed ID: 6798611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat.
    Ruffing D; Kovacic B; Demetriou S; Domino EF
    Psychopharmacology (Berl); 1979 Apr; 62(3):207-10. PubMed ID: 111285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synthetic opioid metenkephalin peptide analogs, Lilly 127623 and FK 33-824 with indole hallucinogens: antagonism of N,N-dimethyltryptamine- and LSD-induced disruption of food-rewarded bar pressing behavior in the rat.
    Ruffing DM; Domino EF
    Psychopharmacology (Berl); 1983; 80(4):315-8. PubMed ID: 6413999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat.
    Kovacic B; Wang Lu LJ; Ruffing D; Domino EF
    Eur J Pharmacol; 1978 Jan; 47(1):37-44. PubMed ID: 271075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats.
    Mokler DJ; Commissaris RL; Henck JW; Rech RH
    Pharmacol Biochem Behav; 1984 Sep; 21(3):333-7. PubMed ID: 6593750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Place-conditioning properties of mu, kappa, and sigma opioid agonists.
    Iwamoto ET
    Alcohol Drug Res; 1985-1986; 6(5):327-39. PubMed ID: 3011025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitter basis of the behavioral effects of hallucinogens.
    Rech RH; Commissaris RL
    Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
    Gatch MB; Rutledge MA; Carbonaro T; Forster MJ
    Psychopharmacology (Berl); 2009 Jul; 204(4):715-24. PubMed ID: 19288085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M; Heise JW; Dykstra LA
    Pharmacol Biochem Behav; 1987 May; 27(1):73-80. PubMed ID: 3615550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute sensitization to opioid antagonists.
    White-Gbadebo D; Holtzman SG
    Pharmacol Biochem Behav; 1994 Mar; 47(3):559-66. PubMed ID: 8208774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of U50,488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists.
    Picker MJ; Doty P; Negus SS; Mattox SR; Dykstra LA
    J Pharmacol Exp Ther; 1990 Jul; 254(1):13-22. PubMed ID: 2164087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cross-tolerance to opioid agonists in morphine-tolerant squirrel monkeys responding under a schedule of food presentation.
    Doty P; Picker MJ; Dykstra LA
    Eur J Pharmacol; 1989 Dec; 174(2-3):171-80. PubMed ID: 2560976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
    Adams LM; Geyer MA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.